Advocates of the use of cannabis-based products say they can be used to treat chronic pain, inflammation, migraines, epilepsy, depression and anxiety, among other ailments.
The use of cannabis for recreational purposes remains banned in Zimbabwe and thousands of people have been arrested this year for illegally cultivating the crop as the country tries to fight rampant drug abuse among young people
Zimbabwe has cleared the way for cannabis-based medical products to be sold for the first time as the southern African country eyes the industry valued at Sh148.5 billion ($1.25 billion).
The Medicines Control of Zimbabwe (MCZ) has opened applications for cannabis and hemp producers, manufacturers, importers, exporters and retail pharmacists.
